Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma
出版年份 2020 全文链接
标题
Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-09-24
DOI
10.1111/jgh.15265
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Guidelines Insights: Pancreatic Adenocarcinoma, Version 1.2019
- (2019) Margaret A. Tempero et al. Journal of the National Comprehensive Cancer Network
- NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer
- (2018) Mayumi Hoshikawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Quantification of NK cell activity using whole blood: Methodological aspects of a new test
- (2018) Line Nederby et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Natural Killer Cell IFNγ Secretion is Profoundly Suppressed Following Colorectal Cancer Surgery
- (2018) Leonard Angka et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor Microenvironment-Induced Immunometabolic Reprogramming of Natural Killer Cells
- (2018) Andrea M. Chambers et al. Frontiers in Immunology
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
- (2015) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- A high-throughput assay of NK cell activity in whole blood and its clinical application
- (2014) Saet-byul Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reduction of the CD16−CD56bright NK Cell Subset Precedes NK Cell Dysfunction in Prostate Cancer
- (2013) Kyo Chul Koo et al. PLoS One
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity
- (2008) Ching-Yi Lin et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started